Cargando…

TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival

Tuberous sclerosis complex (TSC) is caused by mutations in TSC1 or TSC2 genes. Lymphangioleiomyomatosis (LAM) can be sporadic or associated with TSC and is characterized by widespread pulmonary proliferation of abnormal α-smooth muscle (ASM)-like cells. We investigated the features of ASM cells isol...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesma, Elena, Ancona, Silvia, Sirchia, Silvia M, Orpianesi, Emanuela, Grande, Vera, Colapietro, Patrizia, Chiaramonte, Eloisa, Di Giulio, Anna Maria, Gorio, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119383/
https://www.ncbi.nlm.nih.gov/pubmed/24606538
http://dx.doi.org/10.1111/jcmm.12237
_version_ 1782328961643053056
author Lesma, Elena
Ancona, Silvia
Sirchia, Silvia M
Orpianesi, Emanuela
Grande, Vera
Colapietro, Patrizia
Chiaramonte, Eloisa
Di Giulio, Anna Maria
Gorio, Alfredo
author_facet Lesma, Elena
Ancona, Silvia
Sirchia, Silvia M
Orpianesi, Emanuela
Grande, Vera
Colapietro, Patrizia
Chiaramonte, Eloisa
Di Giulio, Anna Maria
Gorio, Alfredo
author_sort Lesma, Elena
collection PubMed
description Tuberous sclerosis complex (TSC) is caused by mutations in TSC1 or TSC2 genes. Lymphangioleiomyomatosis (LAM) can be sporadic or associated with TSC and is characterized by widespread pulmonary proliferation of abnormal α-smooth muscle (ASM)-like cells. We investigated the features of ASM cells isolated from chylous thorax of a patient affected by LAM associated with TSC, named LAM/TSC cells, bearing a germline TSC2 mutation and an epigenetic defect causing the absence of tuberin. Proliferation of LAM/TSC cells is epidermal growth factor (EGF)-dependent and blockade of EGF receptor causes cell death as we previously showed in cells lacking tuberin. LAM/TSC cells spontaneously detach probably for the inactivation of the focal adhesion kinase (FAK)/Akt/mTOR pathway and display the ability to survive independently from adhesion. Non-adherent LAM/TSC cells show an extremely low proliferation rate consistent with tumour stem-cell characteristics. Moreover, LAM/TSC cells bear characteristics of stemness and secrete high amount of interleukin (IL)-6 and IL-8. Anti-EGF receptor antibodies and rapamycin affect proliferation and viability of non-adherent cells. In conclusion, the understanding of LAM/TSC cell features is important in the assessment of cell invasiveness in LAM and TSC and should provide a useful model to test therapeutic approaches aimed at controlling their migratory ability.
format Online
Article
Text
id pubmed-4119383
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-41193832014-12-03 TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival Lesma, Elena Ancona, Silvia Sirchia, Silvia M Orpianesi, Emanuela Grande, Vera Colapietro, Patrizia Chiaramonte, Eloisa Di Giulio, Anna Maria Gorio, Alfredo J Cell Mol Med Original Articles Tuberous sclerosis complex (TSC) is caused by mutations in TSC1 or TSC2 genes. Lymphangioleiomyomatosis (LAM) can be sporadic or associated with TSC and is characterized by widespread pulmonary proliferation of abnormal α-smooth muscle (ASM)-like cells. We investigated the features of ASM cells isolated from chylous thorax of a patient affected by LAM associated with TSC, named LAM/TSC cells, bearing a germline TSC2 mutation and an epigenetic defect causing the absence of tuberin. Proliferation of LAM/TSC cells is epidermal growth factor (EGF)-dependent and blockade of EGF receptor causes cell death as we previously showed in cells lacking tuberin. LAM/TSC cells spontaneously detach probably for the inactivation of the focal adhesion kinase (FAK)/Akt/mTOR pathway and display the ability to survive independently from adhesion. Non-adherent LAM/TSC cells show an extremely low proliferation rate consistent with tumour stem-cell characteristics. Moreover, LAM/TSC cells bear characteristics of stemness and secrete high amount of interleukin (IL)-6 and IL-8. Anti-EGF receptor antibodies and rapamycin affect proliferation and viability of non-adherent cells. In conclusion, the understanding of LAM/TSC cell features is important in the assessment of cell invasiveness in LAM and TSC and should provide a useful model to test therapeutic approaches aimed at controlling their migratory ability. BlackWell Publishing Ltd 2014-05 2014-03-07 /pmc/articles/PMC4119383/ /pubmed/24606538 http://dx.doi.org/10.1111/jcmm.12237 Text en © 2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Lesma, Elena
Ancona, Silvia
Sirchia, Silvia M
Orpianesi, Emanuela
Grande, Vera
Colapietro, Patrizia
Chiaramonte, Eloisa
Di Giulio, Anna Maria
Gorio, Alfredo
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
title TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
title_full TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
title_fullStr TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
title_full_unstemmed TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
title_short TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
title_sort tsc2 epigenetic defect in primary lam cells. evidence of an anchorage-independent survival
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119383/
https://www.ncbi.nlm.nih.gov/pubmed/24606538
http://dx.doi.org/10.1111/jcmm.12237
work_keys_str_mv AT lesmaelena tsc2epigeneticdefectinprimarylamcellsevidenceofananchorageindependentsurvival
AT anconasilvia tsc2epigeneticdefectinprimarylamcellsevidenceofananchorageindependentsurvival
AT sirchiasilviam tsc2epigeneticdefectinprimarylamcellsevidenceofananchorageindependentsurvival
AT orpianesiemanuela tsc2epigeneticdefectinprimarylamcellsevidenceofananchorageindependentsurvival
AT grandevera tsc2epigeneticdefectinprimarylamcellsevidenceofananchorageindependentsurvival
AT colapietropatrizia tsc2epigeneticdefectinprimarylamcellsevidenceofananchorageindependentsurvival
AT chiaramonteeloisa tsc2epigeneticdefectinprimarylamcellsevidenceofananchorageindependentsurvival
AT digiulioannamaria tsc2epigeneticdefectinprimarylamcellsevidenceofananchorageindependentsurvival
AT gorioalfredo tsc2epigeneticdefectinprimarylamcellsevidenceofananchorageindependentsurvival